biotech / news / / Devdiscourse
An experimental drug from Revolution Medicines has shown promising trial results.
Revolution Medicines' experimental drug daraxonrasib nearly doubled survival for pancreatic cancer patients in trials.
KEY POINTS
- Argentina's health ministry will test rodents in Ushuaia after a hantavirus outbreak linked to a cruise ship.
- The CDC is monitoring U.S. passengers after the hantavirus incident involving Dutch travelers reported by the WHO.
- CVS Health raised profit forecasts following effective medical cost controls and stronger first-quarter earnings.
- Eli Lilly will invest an additional $4.5 billion in Indiana for new weight-loss drug production.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →